Givaudan and Nestlé: a Challenging First Semester for the two Swiss Health Valley Powerhouses

Two of Switzerland’s biggest names in industry unveiled their half-year results on Thursday, and the stock market did not respond well. Givaudan and Nestlé, both based in the Lake Geneva region, saw their share prices fall sharply at the opening bell, driven by disappointing figures despite some encouraging signs.

At Givaudan, the flavour and fragrance giant, demand has waned slightly over the first six months of the year: revenue fell slightly (minus 1,7%), weighed down by the Taste & Wellness division, whilst the fragrance and beauty divisions fared well. Profitability also declined, and net profit fell significantly. There is some good news, however: the second quarter showed an improvement, with sales picking up again, suggesting that the worst may be behind us.

As for Nestlé, the fall in turnover is mainly due to a strong Swiss franc, which weighs heavily on the food and drink group’s accounts when its revenue (minus 2,5%) is converted from foreign currencies. Once this currency effect is factored out, sales are indeed rising, driven by both higher volumes and price increases. Chief Executive Philipp Navratil is keen to reassure, citing an accelerating growth momentum, particularly in emerging markets, and confirming the targets for the year.

Another key development for Nestlé: the group is partnering with the Platinum Equity fund to create Peranel, a new joint venture dedicated to premium waters and beverages. It will bring together well-known brands such as S.Pellegrino, Perrier and Acqua Panna under one roof, with the aim of better responding to a rapidly evolving market. The deal, which values this business at nearly €4.9 billion, is expected to be finalised by mid-2027.

➡️ Source: Givaudan, Nestlé, SMI | 📸 ©Canva Media Library